Homepage4516 • TYO
add
Nippon Shinyaku Co Ltd
Vorige slotkoers
¥ 5.092,00
Dag-range
¥ 5.078,00 - ¥ 5.190,00
Jaar-range
¥ 2.967,00 - ¥ 6.529,00
Beurswaarde
358,63 mld. JPY
Gem. volume
297,41K
Koers/winst
11,52
Dividendrendement
2,43%
Primaire beurs
TYO
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (JPY) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 47,49 mld. | 13,10% |
Bedrijfskosten | 18,06 mld. | 36,52% |
Netto inkomsten | 10,08 mld. | -17,20% |
Netto winstmarge | 21,23 | -26,82% |
Winst per aandeel | — | — |
EBITDA | 14,41 mld. | -12,27% |
Effectief belastingtarief | 23,57% | — |
Balans
Totale activa
Totale passiva
| (JPY) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 60,77 mld. | 9,65% |
Totale activa | 328,11 mld. | 15,34% |
Totale passiva | 43,91 mld. | 19,73% |
Totaal aandelenvermogen | 284,20 mld. | — |
Uitstaande aandelen | 67,40 mln. | — |
Koers-boekwaardeverhouding | 1,21 | — |
Rendement op activa | 10,20% | — |
Rendement op kapitaal | 11,61% | — |
Kasstroom
Nettomutatie in liquide middelen
| (JPY) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 10,08 mld. | -17,20% |
Operationele kasstroom | -1,94 mld. | -219,60% |
Kasstroom uit beleggingen | 775,00 mln. | -59,78% |
Kasstroom uit financiering | -4,35 mld. | -2,21% |
Nettomutatie in liquide middelen | -4,52 mld. | -367,91% |
Vrije kasstroom | -2,12 mld. | -141,86% |
Over
Nippon Shinyaku Co., Ltd. is a Japanese pharmaceutical company headquartered in Kyoto that develops, manufactures, and markets prescription drugs and functional foods. Founded in 1911, the company initially focused on herbal medicines before expanding into modern pharmaceuticals, with current therapeutic areas including urology, hematology, intractable and rare diseases, and gynecology. Nippon Shinyaku is listed on the Tokyo Stock Exchange and has developed treatments such as viltolarsen for Duchenne muscular dystrophy. Wikipedia
Opgericht
1 okt 1919
Website
Werknemers
2.243
